Tender detail
Non-exclusive discount agreement for medicines containing formoterol
Summary
The tender concerns non-exclusive pharmaceutical discount agreements for medicines containing formoterol, ATC R03AC13, excluding IHP in the 6 µg strength. DAK-Gesundheit intends to conclude discount agreements with as many interested pharmaceutical companies as possible under the authorisation model. The agreements are planned to run from 1 October 2026 to 30 September 2028, with a one-time 12-month extension option, and will end automatically when an exclusive agreement enters into force. Precise participation and submission requirements must be checked in the official tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.